Kitazato Corporation (TYO:368A)
Japan · Delayed Price · Currency is JPY 1,650.00
-38.00 (-2.25%)
Aug 1, 2025, 3:30 PM JST
ANSYS Revenue
In the fiscal year ending March 31, 2025, Kitazato had annual revenue of 10.30B JPY with 2.20% growth. Kitazato had revenue of 3.04B in the quarter ending March 31, 2025.
Revenue
10.30B
Revenue Growth
+2.20%
P/S Ratio
6.41
Revenue / Employee
119.79M
Employees
86
Market Cap
66.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 10.30B | 222.00M | 2.20% |
| Mar 31, 2024 | 10.08B | 732.00M | 7.83% |
| Mar 31, 2023 | 9.35B | 1.21B | 14.83% |
| Mar 31, 2022 | 8.14B | 1.37B | 20.31% |
| Mar 31, 2021 | 6.77B | -662.04M | -8.91% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 866.03B |
| Otsuka Holdings | 2,393.18B |
| Terumo | 1,036.17B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |